The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 330:141-143 January 13, 1994 Number 2
NextNext

Treatment for Post-Irradiation Xerostomia

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Johnson, J. T.
To the Editor: Johnson et al. (Aug. 5 issue)1 found that oral pilocarpine improved saliva production and relieved the symptoms of xerostomia after irradiation for cancer of the head and neck. They state that other drugs have no proved clinical benefit.

Carbachol, another parasympathomimetic drug, has also been used in functional bladder and gastrointestinal disorders to stimulate the bowel function. Its side effects include sweating, nausea and emesis, hypersalivation, and in large doses, bradycardia.

We recently treated 16 patients with radiation-induced xerostomia, first with oral pilocarpine solution (6 mg three times daily) for three months and then, after a four-week . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.